Impact of Exclusive Enteral Nutrition Therapy on Sperm Quality of Patients With Crohn's Disease
- Conditions
- Crohn's Disease
- Interventions
- Dietary Supplement: Exclusive Enteral Nutrition Therapy
- Registration Number
- NCT02233062
- Lead Sponsor
- Jinling Hospital, China
- Brief Summary
The purpose of this study is to investigate the impact of enteral nutrition therapy on sperm quality of patients with crohn's disease.
- Detailed Description
The highest age- and sex-adjusted incidence rates for Crohn's Disease (CD) occur during the peak reproductive years. In addition, gastroenterologists frequently advise and manage patients with CD who desire to conceive. Enteral nutrition therapy is effective for induction and maintenance of remission in reproductive age men with CD. However, there is no available data on the effects of enteral nutrition therapy on semen quality. The purpose of this study is to investigate the impact of enteral nutrition therapy on sperm quality of patients with CD.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 12
- Clinical diagnosis of Crohn' Disease
- Male patients
- Age: 18-40 years old
- Receive 3-months exclusive enteral nutrition therapy
- Used any experimental therapy in the 8 weeks before study entry date
- Had previously documented problems with male reproductive health, such as low sperm count, impotence, or malignancy
- The use of concomitant medication including sulphasalazine, 5-aminosalicylic acid or other immune-suppressives.
- Unable to complete the 3-months exclusive enteral nutrition therapy.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Semen quality Exclusive Enteral Nutrition Therapy -
- Primary Outcome Measures
Name Time Method Sperm motility Up to 3 months Sperm motility is a useful marker of sperm quality. The normal level of sperm motility (World Health Organization criteria) should be higher than 50%.
- Secondary Outcome Measures
Name Time Method Crohn's Disease Activity Index Up to 3 months
Trial Locations
- Locations (1)
Department of General Surgery, Jinling Hospital
🇨🇳Nanjing, Jiangsu, China